This content was written and submitted by the supplier. It has only been modified to comply with this publication’s space and style.
Bilcare Research AG has recently announced the acquisition of a new site in Singapore. In addition to this new production facility in Asia, the company is expanding the capacity at its premises in Bötzingen, Germany, to meet the demand of the continuously growing pharmaceutical market.
For the domestic markets in Europe, capacity for barrier films has been continuously increased in recent months. These initiatives are part of an overall investment volume of 50 Million Euro and will be completed shortly.
"With these initiatives we will not only increase capacity, but will greatly enhance work safety, hygiene and environmental protection", said Andreas Pfefferle, Global Business Unit Head Pharma Packaging Innovations. "The high quality of our pharmaceutical-packaging films is worldwide well established. From Bötzingen we deliver mono-films as well as coated and laminated films from one production site and continuously develop the global pharmaceutical films business further."
